Literature DB >> 12084264

High grade prostatic intraepithelial neoplasia is a disease.

M S Steiner1.   

Abstract

High grade prostatic intraepithelial neoplasia (PIN) is now widely accepted as the main premalignant lesion that has the potential to progress to prostate adenocarcinoma. High grade PIN is a standard diagnosis that must be included as part of the reported pathologic evaluation of prostate biopsies. Premalignant lesions that affect other organs have been identified and are treated when diagnosed such that the premalignant lesions itself are a disease (eg, carcinoma in situ of the bladder, colon polyps, and cervical dysplasia). Urologists should recognize that high grade PIN is a dangerous lesion and that it should be aggressively managed either by saturation biopsies of the prostate following the diagnosis of high grade PIN, or the more common recommendation--repeated prostate biopsies every 3 to 6 months for 2 years, then annually. Treatment of these precancerous lesions would appear to be of clinical benefit notwithstanding the potential for cancer prevention. These clinical benefits would reduce morbidity, enhance the quality of life, delay surgery or radiation, and increase the interval for surveillance requiring invasive procedures.

Entities:  

Mesh:

Year:  2001        PMID: 12084264     DOI: 10.1007/s11934-001-0078-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  35 in total

Review 1.  Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention.

Authors:  D G Bostwick; R Neumann; J Qian; L Cheng
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

2.  Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance.

Authors:  K C Balaji; F Rabbani; H Tsai; A Bastar; W R Fair
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

3.  Origins of prostate cancer.

Authors:  R Montironi; D G Bostwick; H Bonkhoff; A T Cockett; B Helpap; P Troncoso; D Waters
Journal:  Cancer       Date:  1996-07-15       Impact factor: 6.860

4.  Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention.

Authors:  W A Sakr
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

Review 5.  Chemoprevention of prostate cancer: concepts and strategies.

Authors:  G J Kelloff; R Lieberman; V E Steele; C W Boone; R A Lubet; L Kopelovitch; W A Malone; J A Crowell; C C Sigman
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

6.  The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.

Authors:  C G Ramos; G F Carvahal; D E Mager; B Haberer; W J Catalona
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

7.  Incidence of prostatic intra-epithelial neoplasia in Osaka, Japan.

Authors:  M Q Fujita; M Shin; Y Yasunaga; K Sekii; H Itatani; T Tsujimura; T Miki; A Okuyama; K Aozasa
Journal:  Int J Cancer       Date:  1997-12-10       Impact factor: 7.396

Review 8.  Prostatic intraepithelial neoplasia (PIN): current concepts.

Authors:  D G Bostwick
Journal:  J Cell Biochem Suppl       Date:  1992

9.  Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study.

Authors:  L Vailancourt; B Ttu; Y Fradet; A Dupont; J Gomez; L Cusan; E R Suburu; P Diamond; B Candas; F Labrie
Journal:  Am J Surg Pathol       Date:  1996-01       Impact factor: 6.394

Review 10.  The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials.

Authors:  D G Bostwick; H B Burke; T M Wheeler; L W Chung; R Bookstein; T G Pretlow; R B Nagle; R Montironi; M M Lieber; R W Veltri
Journal:  J Cell Biochem Suppl       Date:  1994
View more
  4 in total

1.  High-grade prostatic intraepithelial neoplasia.

Authors:  David G Bostwick; Lina Liu; Michael K Brawer; Junqi Qian
Journal:  Rev Urol       Date:  2004

2.  Prostatic intraepithelial neoplasia: an overview.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2005

3.  TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Authors:  Kyung Park; James T Dalton; Ramesh Narayanan; Christopher E Barbieri; Michael L Hancock; David G Bostwick; Mitchell S Steiner; Mark A Rubin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

Review 4.  High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction.

Authors:  Mitchell S Steiner
Journal:  World J Urol       Date:  2003-02-21       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.